Kenvue Inc. logo
Kenvue Inc. (KVUE)
Compare

KVUE Cash Flow Statement

Operating, investing, and financing cash flow analysis

KVUE Quarterly Cash Flow Statement (USD)

Quarterly ReportTTM
03/29/2026
12/28/2025
09/28/2025
06/29/2025
03/30/2025
12/31/2024
09/29/2024
06/30/2024
2.258B489.000M854.000M294.000M621.000M428.000M793.000M249.000M440.000M
1.622B474.000M330.000M398.000M420.000M322.000M293.000M383.000M58.000M
564.000M143.000M138.000M141.000M142.000M136.000M150.000M182.000M141.000M
121.000M29.000M30.000M25.000M37.000M44.000M54.000M58.000M61.000M
Change in Accounts Receivable
9.630B2.501B2.382B2.416B2.331B2.312B2.165B2.394B2.240B
Change in Inventory
Change in Accounts Payable
Change in Working Capital
291.000M-203.000M417.000M58.000M19.000M-77.000M262.000M-351.000M-143.000M
Cash from Investing
-435.000M-139.000M-110.000M-98.000M-88.000M-179.000M-132.000M-59.000M-90.000M
0.000.000.000.000.000.000.000.000.00
Cash from Financing
Debt Repayment
-134.000M0.000.00-70.000M-64.000M-63.000M-121.000M-23.000M0.00
-6.000M-398.000M1.183B-398.000M-393.000M-392.000M-393.000M-393.000M-383.000M
1.823B350.000M744.000M196.000M533.000M249.000M661.000M190.000M350.000M
Net Change in Cash
18.000M13.000M-77.000M1.138B-1.056B-13.000M13.000M43.000M-141.000M

KVUE Annual Cash Flow Statement (USD)

Annual Report
12/28/2025
12/29/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
2.197B1.769B3.168B2.525B334.000M3.397B2.998B
1.470B1.030B1.664B2.064B2.078B-879.000M1.435B
557.000M622.000M627.000M644.000M731.000M746.000M709.000M
136.000M254.000M188.000M137.000M141.000M115.000M102.000M
Change in Accounts Receivable
2.382B2.165B2.073B2.122B2.074B1.858B40.000M
Change in Inventory
Change in Accounts Payable
Change in Working Capital
52.000M-571.000M797.000M-513.000M-3.132B4.242B804.000M
Cash from Investing
-475.000M-434.000M-469.000M-375.000M-295.000M-229.000M-289.000M
0.000.0021.000M-10.000M136.000M176.000M-1.846B
Cash from Financing
Debt Repayment
-197.000M-235.000M0.000.000.000.000.00
-1.581B-1.552B-14.554B0.000.000.000.00
1.722B1.335B2.699B2.150B39.000M3.168B2.709B
Net Change in Cash
-8.000M-312.000M151.000M491.000M122.000M-134.000M147.000M

Values are displayed in USD. Negative numbers shown in red.

Values are displayed in USD. Negative numbers are shown in red.

About Kenvue Inc.

Kenvue Inc. functions as a global leader in the consumer health sector. The company structures its operations across three primary divisions: Self Care, Skin Health and Beauty, and Essential Health. Within the Self Care unit, it offers a diverse range of products for common conditions like coughs, colds, and allergies, in addition to pain relief, digestive health, and smoking cessation aids, featuring prominent brands such as Tylenol, Nicorette, and Zyrtec. The Skin Health and Beauty segment delivers various solutions for facial, body, hair, and sun protection, recognized under popular labels including Neutrogena, Aveeno, and OGX. Moreover, the Essential Health category provides oral hygiene, infant care, feminine wellness, and wound treatment products, marketed through esteemed brands like Listerine, Johnson's, Band-Aid, and Stayfree. Established in 2022, Kenvue Inc. maintains its corporate headquarters in Skillman, New Jersey, and operates as a subsidiary of Johnson & Johnson.

Summit, NJ
22,000 employees
Consumer Defensive / Household & Personal Products
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Kirk L. Perry